Reverse Translation in Advancing Pharmacotherapy in Pediatric Rheumatology: A Logical Approach in Rare Diseases with Limited Resources.
Publication
, Journal Article
Becker, ML; Funk, RS
Published in: Clin Transl Sci
March 2018
Duke Scholars
Published In
Clin Transl Sci
DOI
EISSN
1752-8062
Publication Date
March 2018
Volume
11
Issue
2
Start / End Page
106 / 108
Location
United States
Related Subject Headings
- Treatment Outcome
- Translational Research, Biomedical
- Rheumatology
- Rare Diseases
- Methotrexate
- Interleukin 1 Receptor Antagonist Protein
- Humans
- Health Resources
- General Clinical Medicine
- Child
Citation
APA
Chicago
ICMJE
MLA
NLM
Becker, M. L., & Funk, R. S. (2018). Reverse Translation in Advancing Pharmacotherapy in Pediatric Rheumatology: A Logical Approach in Rare Diseases with Limited Resources. Clin Transl Sci, 11(2), 106–108. https://doi.org/10.1111/cts.12513
Becker, Mara L., and Ryan S. Funk. “Reverse Translation in Advancing Pharmacotherapy in Pediatric Rheumatology: A Logical Approach in Rare Diseases with Limited Resources.” Clin Transl Sci 11, no. 2 (March 2018): 106–8. https://doi.org/10.1111/cts.12513.
Becker ML, Funk RS. Reverse Translation in Advancing Pharmacotherapy in Pediatric Rheumatology: A Logical Approach in Rare Diseases with Limited Resources. Clin Transl Sci. 2018 Mar;11(2):106–8.
Becker, Mara L., and Ryan S. Funk. “Reverse Translation in Advancing Pharmacotherapy in Pediatric Rheumatology: A Logical Approach in Rare Diseases with Limited Resources.” Clin Transl Sci, vol. 11, no. 2, Mar. 2018, pp. 106–08. Pubmed, doi:10.1111/cts.12513.
Becker ML, Funk RS. Reverse Translation in Advancing Pharmacotherapy in Pediatric Rheumatology: A Logical Approach in Rare Diseases with Limited Resources. Clin Transl Sci. 2018 Mar;11(2):106–108.
Published In
Clin Transl Sci
DOI
EISSN
1752-8062
Publication Date
March 2018
Volume
11
Issue
2
Start / End Page
106 / 108
Location
United States
Related Subject Headings
- Treatment Outcome
- Translational Research, Biomedical
- Rheumatology
- Rare Diseases
- Methotrexate
- Interleukin 1 Receptor Antagonist Protein
- Humans
- Health Resources
- General Clinical Medicine
- Child